Amgen Inc.
Brak transakcji
Brak transakcji
Korporacyjne papiery dłużne
Poniżej znajduje się lista obligacji Amgen Inc., posortowana według wskaźnika yield to worst. Inwestorzy często wybierają obligacje spółek ze względu na ich większą stabilność w okresach zmienności rynkowej. Analizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTW % | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Rating S&P | Ocena kredytowa Fitch | Rating Moody's | Emitent |
|---|---|---|---|---|---|---|---|---|---|---|
 AMGN.GAAmgen Inc. 8.125% 01-APR-2097 | 6,79% | 119,34% | 8,125% | 2097-04-01 | 100 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DU1Amgen Inc. 5.75% 02-MAR-2063 | 6,70% | 87,04% | 5,750% | 2063-03-02 | 2,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DG2Amgen Inc. 4.4% 22-FEB-2062 | 6,63% | 69,71% | 4,400% | 2062-02-22 | 1,13 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DT4Amgen Inc. 5.65% 02-MAR-2053 | 6,61% | 87,98% | 5,650% | 2053-03-02 | 4,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US031162CF59Amgen Inc. 4.663% 15-JUN-2051 | 6,60% | 76,58% | 4,663% | 2051-06-15 | 3,54 B USD | 1 000,00 USD | BBB+ | — | Baa1 | Amgen, Inc. |
| AMGN6315610Amgen Inc. 5.5% 19-FEB-2046 | 6,59% | 88,76% | 5,500% | 2046-02-19 | 500 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DK3Amgen Inc. 4.875% 01-MAR-2053 | 6,59% | 78,61% | 4,875% | 2053-03-01 | 1 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGDAmgen Inc. 4.2% 22-FEB-2052 | 6,58% | 70,82% | 4,200% | 2052-02-22 | 881,72 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162BZ2Amgen Inc. 4.4% 01-MAY-2045 | 6,54% | 77,19% | 4,400% | 2045-05-01 | 2,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN6315611Amgen Inc. 5.65% 19-FEB-2056 | 6,51% | 88,71% | 5,650% | 2056-02-19 | 750 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN3854930Amgen Inc. 5.375% 15-MAY-2043 | 6,51% | 88,52% | 5,375% | 2043-05-15 | 184,88 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN4437315Amgen Inc. 4.563% 15-JUN-2048 | 6,49% | 77,71% | 4,563% | 2048-06-15 | 1,42 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DS6Amgen Inc. 5.6% 02-MAR-2043 | 6,47% | 91,25% | 5,600% | 2043-03-02 | 2,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN5186584Amgen Inc. 2.77% 01-SEP-2053 | 6,44% | 53,10% | 2,770% | 2053-09-01 | 939,92 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US031162BH25Amgen Inc. 5.65% 15-JUN-2042 | 6,42% | 92,37% | 5,650% | 2042-06-15 | 415,42 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162CS7Amgen Inc. 3.375% 21-FEB-2050 | 6,42% | 63,36% | 3,375% | 2050-02-21 | 1,27 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US031162BE93Amgen Inc. 4.95% 01-OCT-2041 | 6,40% | 86,06% | 4,950% | 2041-10-01 | 600 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN.HGAmgen Inc. 5.15% 15-NOV-2041 | 6,37% | 88,26% | 5,150% | 2041-11-15 | 728,89 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US031162BC38Amgen Inc. 5.75% 15-MAR-2040 | 6,32% | 94,83% | 5,750% | 2040-03-15 | 373,1 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162CR9Amgen Inc. 3.15% 21-FEB-2040 | 6,30% | 71,74% | 3,150% | 2040-02-21 | 1,48 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN.GVAmgen Inc. 6.4% 01-FEB-2039 | 6,25% | 102,98% | 6,400% | 2039-02-01 | 333,01 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN.GUAmgen Inc. 6.9% 01-JUN-2038 | 6,23% | 104,76% | 6,900% | 2038-06-01 | 253,28 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN5235282Amgen Inc. 2.8% 15-AUG-2041 | 6,21% | 67,16% | 2,800% | 2041-08-15 | 543,17 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN.GRAmgen Inc. 6.375% 01-JUN-2037 | 6,05% | 102,05% | 6,375% | 2037-06-01 | 478,88 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN6315002Amgen Inc. 4.85% 19-FEB-2036 | 5,98% | 91,59% | 4,850% | 2036-02-19 | 1,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN5235280Amgen Inc. 3.0% 15-JAN-2052 | 5,94% | 61,73% | 3,000% | 2052-01-15 | 598,26 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DR8Amgen Inc. 5.25% 02-MAR-2033 | 5,88% | 96,65% | 5,250% | 2033-03-02 | 4,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DJ6Amgen Inc. 4.2% 01-MAR-2033 | 5,86% | 91,22% | 4,200% | 2033-03-01 | 750 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DE7Amgen Inc. 3.35% 22-FEB-2032 | 5,72% | 89,14% | 3,350% | 2032-02-22 | 1 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN5235281Amgen Inc. 2.0% 15-JAN-2032 | 5,66% | 83,37% | 2,000% | 2032-01-15 | 986,62 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN4984121Amgen Inc. 2.3% 25-FEB-2031 | 5,63% | 87,22% | 2,300% | 2031-02-25 | 1,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN6315612Amgen Inc. 4.2% 19-FEB-2031 | 5,60% | 94,55% | 4,200% | 2031-02-19 | 1 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162CU2Amgen Inc. 2.45% 21-FEB-2030 | 5,57% | 90,49% | 2,450% | 2030-02-21 | 1,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DQ0Amgen Inc. 5.25% 02-MAR-2030 | 5,54% | 99,09% | 5,250% | 2030-03-02 | 2,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DH0Amgen Inc. 4.05% 18-AUG-2029 | 5,39% | 96,47% | 4,050% | 2029-08-18 | 1,25 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DD9Amgen Inc. 3.0% 22-FEB-2029 | 5,36% | 94,76% | 3,000% | 2029-02-22 | 750 M USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGCAmgen Inc. 4.0% 13-SEP-2029 | 5,24% | 96,69% | 4,000% | 2029-09-13 | 700 M GBP | 1 000,00 GBP | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGN5235279Amgen Inc. 1.65% 15-AUG-2028 | 5,23% | 93,75% | 1,650% | 2028-08-15 | 1,23 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162DP2Amgen Inc. 5.15% 02-MAR-2028 | 5,15% | 99,99% | 5,150% | 2028-03-02 | 3,75 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162CQ1Amgen Inc. 3.2% 02-NOV-2027 | 4,94% | 98,19% | 3,200% | 2027-11-02 | 1 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| US31162CT5Amgen Inc. 2.2% 21-FEB-2027 | 4,63% | 99,11% | 2,200% | 2027-02-21 | 1,72 B USD | 1 000,00 USD | BBB+ | BBB+ | Baa1 | Amgen, Inc. |
| AMGAAmgen Inc. 5.5% 07-DEC-2026 | 4,30% | 100,19% | 5,500% | 2026-12-07 | 475 M GBP | 1 000,00 GBP | BBB+ | BBB+ | Baa1 | Amgen, Inc. |